Versican Plus Pi/L4R

Unknown🇪🇺 European Union

EMA Page

Authorised Date: N/A
Approval ID: 1b2d508efe48db9e
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

Up-to-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website](https://medicines.health.europa.eu/veterinary/select-language?destination=/node/210934 "(opens in a new window)")

Therapeutic & Classification

Therapeutic Indication

N/A

Therapeutic Area (MeSH)

N/A

ATC Code

N/A

ATC Item

N/A

Pharmacotherapeutic Group

N/A

Active Substances

Active Substance (Summary)

canine parainfluenza virus, leptospira and rabies virus.

INN / Common Names

canine parainfluenza virus, leptospira and rabies virus

Active Substance Details

Substance	CAS	Monograph
canine parainfluenza virus, leptospira and rabies virus.	N/A	canine parainfluenza virus, leptospira and rabies virus.

Quick Info

Approval ID1b2d508efe48db9e

Product NumberN/A

StatusAuthorised

Authorised DateN/A

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Versican Plus Pi/L4R

Medicine Name

Versican Plus Pi/L4R

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals